vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.0倍（$14.0M vs $13.7M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -10.3%，领先20.1%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 10.4%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-736.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 24.6%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
CPIX vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.0倍
$13.7M
营收增速更快
CPIX
高出20.7%
10.4%
净利率更高
RVSB
高出20.1%
-10.3%
自由现金流更多
CPIX
多$739.0K
$-736.0K
两年增速更快
CPIX
近两年复合增速
24.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $14.0M |
| 净利润 | $-1.4M | $1.4M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 12.4% |
| 净利率 | -10.3% | 9.8% |
| 营收同比 | 31.1% | 10.4% |
| 净利润同比 | 25.8% | 11.8% |
| 每股收益（稀释后） | $-0.09 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXRVSB
| Q4 25 | $13.7M | $14.0M | ||
| Q3 25 | $8.3M | $13.6M | ||
| Q2 25 | $10.8M | $13.3M | ||
| Q1 25 | $11.7M | $12.9M | ||
| Q4 24 | $10.4M | $12.7M | ||
| Q3 24 | $9.1M | $12.8M | ||
| Q2 24 | $9.8M | $12.2M | ||
| Q1 24 | $8.5M | $9.0M |
净利润CPIXRVSB
| Q4 25 | $-1.4M | $1.4M | ||
| Q3 25 | $-1.9M | $1.1M | ||
| Q2 25 | $-740.7K | $1.2M | ||
| Q1 25 | $1.3M | $1.1M | ||
| Q4 24 | $-1.9M | $1.2M | ||
| Q3 24 | $-1.5M | $1.6M | ||
| Q2 24 | $-1.1M | $966.0K | ||
| Q1 24 | $-1.9M | $-3.0M |
毛利率CPIXRVSB
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXRVSB
| Q4 25 | -10.0% | 12.4% | ||
| Q3 25 | -23.7% | 10.2% | ||
| Q2 25 | -6.9% | 11.7% | ||
| Q1 25 | 11.0% | 11.3% | ||
| Q4 24 | -17.7% | 12.4% | ||
| Q3 24 | -18.6% | 15.5% | ||
| Q2 24 | -10.4% | 10.0% | ||
| Q1 24 | -22.0% | -47.5% |
净利率CPIXRVSB
| Q4 25 | -10.3% | 9.8% | ||
| Q3 25 | -23.4% | 8.1% | ||
| Q2 25 | -6.8% | 9.2% | ||
| Q1 25 | 10.7% | 8.9% | ||
| Q4 24 | -18.2% | 9.7% | ||
| Q3 24 | -17.0% | 12.2% | ||
| Q2 24 | -11.0% | 7.9% | ||
| Q1 24 | -22.9% | -34.7% |
每股收益（稀释后）CPIXRVSB
| Q4 25 | $-0.09 | $0.07 | ||
| Q3 25 | $-0.13 | $0.05 | ||
| Q2 25 | $-0.05 | $0.06 | ||
| Q1 25 | $0.08 | $0.05 | ||
| Q4 24 | $-0.13 | $0.06 | ||
| Q3 24 | $-0.11 | $0.07 | ||
| Q2 24 | $-0.08 | $0.05 | ||
| Q1 24 | $-0.14 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $164.2M |
| 总资产 | $76.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXRVSB
| Q4 25 | $11.4M | $28.6M | ||
| Q3 25 | $15.2M | $32.8M | ||
| Q2 25 | $16.1M | $34.2M | ||
| Q1 25 | $15.1M | $29.4M | ||
| Q4 24 | $18.0M | $25.3M | ||
| Q3 24 | $17.5M | $31.0M | ||
| Q2 24 | $17.3M | $27.8M | ||
| Q1 24 | $18.5M | $23.6M |
股东权益CPIXRVSB
| Q4 25 | $24.9M | $164.2M | ||
| Q3 25 | $26.1M | $163.5M | ||
| Q2 25 | $28.0M | $162.0M | ||
| Q1 25 | $28.7M | $160.0M | ||
| Q4 24 | $22.9M | $158.3M | ||
| Q3 24 | $24.8M | $160.8M | ||
| Q2 24 | $26.3M | $155.9M | ||
| Q1 24 | $27.5M | $155.6M |
总资产CPIXRVSB
| Q4 25 | $76.8M | $1.5B | ||
| Q3 25 | $65.9M | $1.5B | ||
| Q2 25 | $67.9M | $1.5B | ||
| Q1 25 | $69.9M | $1.5B | ||
| Q4 24 | $75.6M | $1.5B | ||
| Q3 24 | $76.7M | $1.5B | ||
| Q2 24 | $78.5M | $1.5B | ||
| Q1 24 | $81.5M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-736.0K |
| 自由现金流率自由现金流/营收 | 0.0% | -5.2% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $20.4M |
8季度趋势，按日历期对齐
经营现金流CPIXRVSB
| Q4 25 | $3.0K | $-506.0K | ||
| Q3 25 | $187.2K | $16.8M | ||
| Q2 25 | $843.8K | $-697.0K | ||
| Q1 25 | $3.9M | $8.3M | ||
| Q4 24 | $1.9M | $2.2M | ||
| Q3 24 | $475.5K | $764.0K | ||
| Q2 24 | $-855.7K | $5.4M | ||
| Q1 24 | $-2.1M | $12.8M |
自由现金流CPIXRVSB
| Q4 25 | $3.0K | $-736.0K | ||
| Q3 25 | $163.4K | $16.4M | ||
| Q2 25 | $817.3K | $-773.0K | ||
| Q1 25 | $3.9M | $5.6M | ||
| Q4 24 | $1.9M | $1.9M | ||
| Q3 24 | $460.1K | $-1.4M | ||
| Q2 24 | $-862.8K | $5.3M | ||
| Q1 24 | $-2.2M | $7.1M |
自由现金流率CPIXRVSB
| Q4 25 | 0.0% | -5.2% | ||
| Q3 25 | 2.0% | 120.1% | ||
| Q2 25 | 7.5% | -5.8% | ||
| Q1 25 | 32.9% | 43.1% | ||
| Q4 24 | 18.2% | 15.0% | ||
| Q3 24 | 5.1% | -11.3% | ||
| Q2 24 | -8.8% | 43.7% | ||
| Q1 24 | -25.6% | 79.0% |
资本支出强度CPIXRVSB
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.3% | 2.9% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.4% | 21.0% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.2% | 17.3% | ||
| Q2 24 | 0.1% | 0.9% | ||
| Q1 24 | 0.5% | 62.0% |
现金转化率CPIXRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | 3.10× | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
